Working Committees

The 17 Working Committees of the CIBMTR provide scientific oversight for the use of CIBMTR data and help establish priorities for allocating CIBMTR resources. Working Committee responsibilities include:

• designing and conducting studies relevant to their subject area and involving CIBMTR data, statistical resources, networks and/or centers;
• considering proposals to use CIBMTR data for studies pertinent to their subject area;
• periodically assessing and revising relevant sections of CIBMTR data collection forms and
• planning and conducting workshops at CIBMTR meetings.

Working Committees have responsibility for setting priorities for CIBMTR observational studies using the large clinical databases of the CIBMTR and NMDP. These observational studies are a core activity of the CIBMTR.

Membership is open to anyone wishing to take an active part in the CIBMTR studies. To join a Working Committee, please contact the CIBMTR Statistical Center at cibmtr@mcw.edu

CIBMTR Acute Leukemia Working Committee

(cellular therapy for acute leukemias, preleukemia, and myelodysplastic disorders)

Co-Chairs:	Jorge Sierra, MD
	Martin Tallman, MD
	John DiPersio, MD, PhD
Scientific Director:	Daniel Weisdorf, MD
Statisticians:	Waleska Pérez, MPH
	Mei-Jie Zhang, PhD

CIBMTR Autoimmune Diseases Working Committee

(cellular therapy for autoimmune disorders other than autoimmune cytopenias)

Co-Chairs:	Richard Nash, MD
	Harold Atkins, MD
Scientific Director:	Marcelo Pasquini, MD, MS
Statisticians:	Manza Agovi, MPH
	Brent Logan, PhD

CIBMTR Cellular Therapies Committee

Co-Chairs:	TBD
Scientific Director:	Marcelo Pasquini, MD, MS

CIBMTR Chronic Leukemia Working Committee

(cellular therapy for chronic leukemias and myeloproliferative disorders)

Co-Chairs:	Ann Woolfrey, MD
	Jeffrey Szer, MD
	Jorge Cortes, MD
Scientific Director:	Mukta Arora, MD, MS
Statisticians:	Manisha Kukreja, MBBS, MPH
	Sergey Tarima, PhD

CIBMTR Donor Health & Safety Working Committee

(donor outcomes)

Co-Chairs:	Michael Pulsipher, MD
	Susan Leitman, MD
	David Stroncek, MD
Scientific Director:	Dennis Confer, MD
Statisticians:	Tanya Pedersen
	Brent Logan, PhD

CIBMTR Graft Sources and Manipulation Working Committee

(issues related to graft procurement, quality and manipulation)

Co-Chairs:	Adrian Gee, PhD
	Mary Laughlin, MD
	Richard Champlin, MD
Scientific Director:	Mary Eapen, MD, MS
Statisticians:	Fiona Kan, MS, MA
	Mei-Jie Zhang, PhD

CIBMTR Graft-vs-Host Disease Working Committee

(biology, prevention and treatment of GVHD and its complications)

Co-chairs:	Olle Ringdén, MD, PhD
	Steven Pavletic, MD
	Mary Flowers, MD
Scientific Directors:	Mukta Arora, MD, MS
:	Stephen Spellman, MS
Statisticians:	Dan Wang, MS
	Tao Wang, PhD

CIBMTR Health Policy Working Committee

(access to cellular therapy including social and economic barriers to care and influence of psychosocial factors on outcome)

Co-Chairs:	Stephanie Lee, MD, MPH
	Galen Switzer, PhD
Scientific Directors:	J. Douglas Rizzo, MD, MS
	Navneet Majhail, MD, MS
Statisticians:	Anna Hassabroek, MPH
	John P. Klein, PhD

CIBMTR Immune Deficiencies/Inborn Errors Working Committee

(cellular therapy for congenital and acquire immune deficiencies and inborn errors of metabolism)

Co-Chairs:	Carmen Maria Sales Bonfim, MD
	Mitchell Horwitz, MD
	Paul Veys, MD
Scientific Director:	Mary Eapen, MD, MS
Statisticians:	Anna Hassebroek, MPH
	Sergey Tarima, PhD

CIBMTR Immunobiology Working Committee
(histocompatibility and other genetic and immunologic issues related to cellular therapy)

Co-Chairs:	Machteld Oudshoorn, PhD
	Effie Petersdorf, MD
	David Miklos, MD, PhD
Scientific Directors:	Stephen Spellman, MS
	Stephanie Lee, MD, MPH
Statisticians:	Mike Haagenson, MS
	Fiona Kan, MS, MA
	Tao Wang, PhD
	John P. Klein, PhD

CIBMTR Infection and Immune Reconstitution Working Committee

(prevention and treatment of posttransplant infections and issues related to recovery of immune function)

Co-Chairs:	Jan Storek, MD, PhD
	JoAnne Young, MD
	Juan Gea-Banacloche, MD
Scientific Director:	Marcie Tomblyn, MD, MS
Statisticians:	Manisha Kukreja, MBBS, MPH
	Sergey Tarima, PhD

CIBMTR International Studies Working Committee

Co-Chairs:	Philip Rowlings, MBBS, MD
	Mahmoud Aljurf, MBBS
	David Gomez-Almaguer, MD
Scientific Director:	Marcelo Pasquini, MD, MS

CIBMTR Late Effects and Quality of Life Working Committee

(issues related to long-term survivors of cellular therapy, including clinical and psychosocial effects of transplantation)

Co-Chairs:	John Wingard, MD
	Brian Bolwell, MD
	David Jacobsohn, MD
Scientific Directors:	J. Douglas Rizzo, MD, MS
	Navneet Majhail, MD, MS
Statisticians:	Kathleen A. Sobocinksi, MS
	John P. Klein, PhD

CIBMTR Lymphoma Working Committee

(cellular therapy for Hodgkin and non-Hodgkin disease)

Co-Chairs:	Koen can Biesen, MD
	Hillard Lazarus, MD
	Ginna Laport, MD
Scientific Director:	Parameswaran Hari, MD
Statisticians:	Jeannette Carreras, MPH
	Mei-Jie Zhang, PhD

CIBMTR Non-Malignant Marrow Disorders Working Committee

(cellular therapy for aplastic anemia, congenital disorders of hematopoiesis, autoimmune cytopenias and other non-malignant hematopoietic disorders)

Co-Chairs:	Ricardo Pasquini, MD
	Mark Walters, MD
	Mouhab Ayas, MD
Scientific Director:	Mary Eapen, MD, MS
Statisticians:	Jeannette Carreras, MPH
	Sergey Tarima, PhD

CIBMTR Pediatric Cancer Working Committee

(cellular therapy for childhood malignancies and other issues related to use of cellular therapy in children)

Co-Chairs:	Stephan Grupp, MD
	Stella Davies, MD
	Paul Carpenter, MD
Scientific Director:	Mary Eapen, MD, MS
Statisticians:	Vincent He, MS
	Mei-Jie Zhang, PhD

CIBMTR Plasma Cell Disorders Working Committee

(cellular therapy for multiple myeloma and other plasma cell disorders)

Co-Chairs:	Donna Reece, MD
	Angela Dispenzieri, MD
	Gustavo Milone, MD
Scientific Director:	Parameswaran Hari, MD
Statisticians:	Waleska Pérez, MPH
	Smriti Shresha, MS
	Mei-Jie Zhang, PhD

CIBMTR Regimen-Related Toxicity/Supportive Care Working Committee

(preparative regimens, prevention and treatment of early non-GvHD toxicities and supportive care in the early posttransplant period)

Co-Chairs:	Andrea Bacigalupo, MD
	Karen Ballen, MD
	Vincent Ho, MD
Scientific Director:	J. Douglas Rizzo, MD, MS
Statisticians:	Manza Agovi, MPH
	Brent Logan, PhD

CIBMTR Solid Tumors Working Committee

(cellular therapy for solid tumors)

Co-Chairs:	Richard Childs, MD
	Didier Blaise, MD
	Edward Stadtmauer, MD
Scientific Director:	Mukta Arora, MD, MS
Statisticians:	Kathleen A. Sobocinski, MS
	Sergey Tarima, PhD

Related Topics:
Meeting Materials

Note: To view PDF documents you will need Adobe Reader.